APIE Therapeutics Inc.
APIE Therapeutics is a preclinical Biopharma pioneering a pipeline of drugs to repair and regenerate damage to the small vasculature niche, which is associated to the precursor of many chronic and fibrotic diseases pathophysiology. Our drug portfolio consist of over 800 potent and selective Apelin Receptor Agonists.
APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies.
Employment range in NC
Primary site activity
All company activities